Table 2 Distribution of antimicrobial resistance genotypes and MLSTs among carbapenem-resistant isolates
From: Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
First Author | Economic division | Hospital level | Year of publication | Year data collection | Sample source | CLSI Criteria (year) | Studies type | Community acquired or hospital acquired infection | Organisms and sample size (n) | Resistance gene | MLST | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carbapenemase (n) | β-lactamase genes | Amp C | |||||||||||
He JR et al. | Central China | Tertiary hospitals | 2017 | 2016.9–2016.10 | Blood | 2015 | Case reports | UNK | KP (n = 5) | bla NDM-1 (n = 5) | – | – | – |
Jiang MJ et al. | Eastern China | Tertiary hospitals | 2012 | 2009.7 | Blood | 2011 | Case reports | UNK | KP (n = 1) | bla KPC-2 (n = 1) | bla CTX-M-14 (n = 1), bla SHV-2 (n = 1) | bla DHA-1 (n = 1) | – |
Xu C et al. | Eastern China | Tertiary hospitals | 2015 | 2013.4–2013.5 | Blood | 2013 | Case reports | Hospital acquired | KP (n = 1) | bla NDM-1 (n = 1) | bla TEM-1 (n = 1), | – | ST22 (n = 1) |
Yao MZ et al. | Eastern China | Tertiary hospitals | 2003 | 1997.1–2002.8 | Blood | UNK | Cross-sectional study | UNK | KP (n = 1) | – | – | – | – |
Jiang DQ et al. | Western China | Tertiary hospitals | 2017 | 2013.1–2016.12 | Blood | UNK | Cross-sectional study | UNK | KP (n = 2) | – | – | – | – |
Song HY, et al. | Eastern China | Tertiary hospitals | 2012 | 2009.1–2010.12 | Blood | UNK | Cross-sectional study | UNK | KP (n = 1) | – | – | – | – |
Zhang ZM et al. | Central China | Tertiary hospitals | 2014 | 2011–2013 | Blood | UNK | Cross-sectional study | UNK | KP (n = 18) E. coli (n = 9) | – | – | – | – |
Tai SH, et al. | Central China | Tertiary hospitals | 2017 | 2014.1–2016.6 | Blood | 2013 | Cross-sectional study | UNK | KP (n = 1) | – | – | – | – |
Tian HR, et al. | Western China | Tertiary hospitals | 2016 | 2013.1–2014.12 | Blood | UNK | Cross-sectional study | UNK | KP (n = 7) | – | – | – | – |
Chen S et al. | Western China | Tertiary hospitals | 2014 | 2009.1–2010.12 | Blood | 2010 | Cross-sectional study | Hospital acquired infection | KP (n = 1) | bla IMP-4 (n = 1) | – | – | – |
Jin Y, et al. | Eastern China | Tertiary hospitals | 2015 | 2012.8–2013.9 | Blood | 2013 | Cross-sectional study | Hospital acquired infection | KP (n = 1) | bla NDM-1 (n = 1) | bla TEM-1 (n = 1), bla CTX-M -14 (n = 1), | bla DHA-1 (n = 1) | ST20 (n = 1) |
Zheng R, et al. | Western China | Tertiary hospitals | 2016 | 2014.1–2014.3 | Blood | 2013 | Cross-sectional study | Hospital acquired infection | KP (n = 4) | bla NDM-1 (n = 4), bla IMP-4 (n = 1) | bla CTX-M-15 (n = 4), bla SHV-1 (n = 4) | – | ST105 (n = 4) |
Liu Y, et al. | Eastern China | Tertiary hospitals | 2013 | 2010.6–2010.9 | Blood | 2009 | Cross-sectional study | UNK | KP (n = 1) | bla KPC-2 (n = 1) | bla SHV-12 (n = 1), bla TEM-1 (n = 1), bla CTX-M -14 (n = 1), | – | UD (n = 1) |
Zhang XY, et al. | Central China | Tertiary hospitals | 2015 | 2012.8–2013.3 | Blood | 2012 | Case report | Hospital acquired infection (n = 2) vertical transmission infection (n = 1) | KP (n = 3) | bla NDM-1 (n = 3), | TEM-1 (n = 3), bla CTX-M-15 (n = 3), bla SHV-1(n = 3), | bla CMY-4 (n = 3) | ST17 (n = 3) |
Zhang Y, et al. | Central China | Tertiary hospitals | 2015 | 2013.2.18 | Blood | 2014 | Case report | Hospital acquired infection (n = 1) | KP (n = 1) | 0 | SHV-11 (n = 1), TEM-53 (n = 1), | 0 | ST65 (n = 1) |
Qin SS, et al. | Central China | Tertiary hospitals | 2014 | 2011.6–2012.6 | Blood | 2012 | Cross-sectional study | UNK | KP (n = 1) | bla NDM-1 (n = 1) | bla TEM-1 (n = 1), CTX-M-15(n = 1) | – | ST966 (n = 1) |
E.coli (n = 1) | bla NDM-1 (n = 1) | bla TEM-1(n = 1) | bla CMY-30 (n = 1) | ST40 (n = 1) | |||||||||
Jin Y, et al. | Eastern China | Tertiary hospitals | 2017 | 2013.7.29 | Blood | 2014 | Cross-sectional study | UNK | KP (n = 1) | bla NDM-1 (n = 1) | bla TEM-1(n = 1), bla CTX-M-15 (n = 1) | bla DHA-1 (n = 1) | ST20 (n = 1) |